NCT07418437
Adapting and Pilot Testing a Loneliness Intervention for Cancer Survivors
Enrolling by Invitation
NAAges 18+InterventionalTreatmentUniversity of WashingtonInvestigator-initiated
~36 participants
Updated 2026-06-04 on ClinicalTrials.gov
What's tested:Social Prescribing GroupUsual Care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Loneliness
Measured over Baseline, 9 Weeks, 2 Month Follow Up
Conditions
Where it's being run
1 sites across 1 statesWashington1
Study leadership
- Sebastian Tong, MD, MPH · PRINCIPAL_INVESTIGATOR · University of Washington
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
18 years of age or older
English-speaking
A score greater or equal to 6 on the UCLA Loneliness 3-item Scale
Cancer survivor with a cancer diagnosis
Exclusion
Are on palliative care or live in a controlled setting (i.e., assisted living, nursing home or inpatient treatment facility)
Have an upcoming scheduled surgery
Severe cognitive impairment or active psychosis
What this trial measures
- LonelinessBaseline, 9 Weeks, 2 Month Follow Up
The primary outcome is to see changes in loneliness using the University of California, Los Angeles Loneliness Version 3 (UCLA). It contains 20 questions that ask about loneliness-related experiences. Loneliness score range 0-80 with 80 indicating a maximum value and severe loneliness.